FrancophonIA/ELRC3.0 huggingface dataset:
English: • Tumours known to be eroding into a major blood vessel in or adjacent to the illumination site.
Croatian: • Tumori za koje se zna da zahvaćaju veliku krvnu žilu na mjestu ili blizu mjesta obasjavanja.
English: • There may be swelling or you may have a stiff jaw.
Croatian: • Može nastati otok ili možete imati ukočenu čeljust.
English: Once removed from its package, this medicine must be used immediately.
Croatian: Nakon što se izvadi iz pakiranja, ovaj lijek se mora odmah primijeniti.
English: Special care must be taken to prevent extravasation at the injection site.
Croatian: Mora se posebno paziti da se spriječi ekstravazacija na mjestu injekcije.
English: • Anaemia
Croatian: • Anemija.
English: The pharmacological activity is initiated by photoactivation of temoporfin with non-thermal light at 652 nm following intravenous administration.
Croatian: Farmakološko djelovanje započinje fotoaktivacijom temoporfina hladnom svjetlošću valne duljine 652 nm nakon intravenske primjene.
English: Illumination of airways may lead to local inflammation and oedema.
Croatian: Obasjavanje dišnih puteva može uzrokovati lokalnu upalu ili edem.
English: The patency of the in-dwelling cannula should be tested before injection and every precaution taken against extravasation (see section 4.4).
Croatian: Prije injiciranja potrebno je provjeriti prohodnost uvedene kanile i poduzeti sve mjere opreza da ne dođe do ekstravazacije (vidjeti dio 4.4).
English: Breast-feeding should be discontinued for at least one month following injection of Foscan.
Croatian: Dojenje treba prekinuti na najmanje mjesec dana nakon injekcije Foscana.
English: How to use Foscan
Croatian: Kako primjenjivati Foscan
English: The table of instructions tells you what to do to prevent skin burns.
Croatian: Tablica s uputama o tome kako da spriječite opekotine na koži.
English: The low number of treated patients did not allow identification of adverse reactions, which may be categorised as uncommon and rare.
Croatian: Zbog malog broja liječenih bolesnika, nuspojave koje se javljaju manje često i rijetko, nisu mogle biti identificirane.
English: Foscan must not be diluted with aqueous solutions.
Croatian: Foscan se ne smije razrjeđivati vodenim otopinama.
English: • Foscan will make you sensitive to light for about 15 days after your injection.
Croatian: • Zbog Foscana ćete biti osjetljivi na svjetlost približno 15 dana nakon injekcije.
English: • There may also be bleeding, ulcers, swelling in the treated area like swelling of your face or tongue, and scarring.
Croatian: • Također se može javiti krvarenje, ranice, otečenost u liječenom području poput oticanja lica ili jezika te nastanak ožiljaka.
English: • Airway blocking as consequence of swelling in the treated area
Croatian: • Blokada dišnih puteva kao posljedica oticanja liječenog područja.
English: How to store Foscan
Croatian: Kako čuvati Foscan
English: • Light sensitivity
Croatian: • Osjetljivost na svjetlost.
English: • Scarf: for head and neck.
Croatian: • Šal: za glavu i vrat.
English: Each pack contains 1 vial and a filter with Luer lock connections for syringe and cannula.
Croatian: Jedno pakiranje sadrži 1 bočicu i filtar s nastavkom vrste Luer lock za spajanje sa štrcaljkom ili kanilom.
English: Day 15 onward Your sensitivity to light is gradually getting back to normal.
Croatian: Vaša osjetljivost na svjetlost postupno će se vratiti na uobičajenu razinu.
English: Each vial is a single dose and any unused medicine must be discarded.
Croatian: Jedna bočica je jedna doza i sav neiskorišteni lijek mora se baciti.
English: 96 hours after the administration of Foscan, the treatment site is to be illuminated with light at 652 nm from an approved laser source.
Croatian: Devedeset šest (96) sati nakon primjene Foscana, mjesto liječenja obasjava se svjetlošću valne duljine od 652 nm iz odobrenog laserskog izvora.
English: Serious side effects such as inflammation of bile duct or gallbladder, liver abscess or perforation in the treated area have been reported when used in other cancer than head and neck.
Croatian: Ozbiljne nuspojave poput upale žučovoda ili žučnog mjehura, gnojne nakupine u jetri ili proboja u liječenom području prijavljene su kad se lijek koristio za liječenje drugih vrsta karcinoma, osim karcinoma glave i vrata.
English: • Socks: for feet and ankles.
Croatian: • Čarape: za stopala i gležnjeve.
English: All patients who receive Foscan will become temporarily photosensitive and must be instructed to observe precautions to avoid sunlight and bright indoor light.
Croatian: Svi bolesnici koji primaju Foscan postat će privremeno fotoosjetljivi i mora im se savjetovati da se pridržavaju mjera opreza i izbjegavaju sunčevu svjetlost i jaku umjetnu rasvjetu u zatvorenim prostorima.
English: Each ml contains 1 mg of temoporfin.
Croatian: Jedan ml sadrži 1 mg temoporfina.
English: Do not breast-feed for at least 1 month after Foscan injection.
Croatian: Nemojte dojiti najmanje 1 mjesec nakon injekcije Foscana.
English: • Long sleeved top: for upper body/arms.
Croatian: • Odjeću dugih rukava: za gornji dio tijela/ruke.
English: The incident light dose is 20 J/cm 2, delivered by the microlens fibre-optic in a circular field to the tumour surface at an irradiance of 100 mW/cm 2, implying an illumination time of 200 seconds.
Croatian: Doza upadne svjetlosti je 20 J/cm2, a dostavlja se fiberoskopom s mikrolećom na kružno područje površine tumora intenzitetom zračenja od 100 mW/cm2, što znači da vrijeme obasjavanja iznosi 200
English: Avoid direct sunlight or strong indoor lighting.
Croatian: Izbjegavajte izravnu sunčevu svjetlost ili jaku umjetnu rasvjetu.
English: The amount of alcohol in this medicinal product may impair the ability to drive or use machines.
Croatian: Količina alkohola u ovom lijeku može narušiti sposobnost upravljanja vozilima ili rada na strojevima.
English: Thirty-seven patients received at least 2 treatments with Foscan.
Croatian: Trideset sedam bolesnika primilo je najmanje dva liječenja Foscanom.U deset bolesnika postignut je tumorski odgovor nakon ponovnog liječenja.
English: Thus, an in-line filter must be used as a precautionary measure and is provided in the package.
Croatian: Stoga se kao mjera opreza mora koristiti ugrađeni filtar, koji je priložen u pakiranju.
English: Solution for injection 1 mg/1 ml Solution for injection 3 mg/3 ml Solution for injection 6 mg/6 ml Sterile filter
Croatian: Otopina za injekciju 1 mg/1 ml Otopina za injekciju 3 mg/3 ml Otopina za injekciju 6 mg/6 ml Sterilni filtar
English: • You may also get ulcers, blisters, skin redness, or skin darkening.
Croatian: • Također mogu nastati ranice, mjehurići, crvenilo kože ili tamnjenje kože.
English: Foscan is administered via an in-dwelling intravenous cannula in a large proximal limb vein, preferably in the antecubital fossa, as a single slow intravenous injection over not less than 6 minutes.
Croatian: Foscan se primjenjuje putem uvedene intravenske kanile postavljene u veliku venu na gornjem ekstremitetu, po mogućnosti u lakatnoj jami, kao jednokratna spora intravenska injekcija u trajanju od najmanje 6 minuta.
English: For 30 days following Foscan treatment, avoid eye tests that use bright lights.
Croatian: Tijekom 30 dana nakon liječenja Foscanom, izbjegavajte očne preglede koji se provode jarkim svjetlom.
English: Ethanol, anhydrous (E1510) Propylene glycol (E1520)
Croatian: 6.1 Popis pomoćnih tvari etanol, bezvodni (E1510) propilenglikol (E1520)
English: Foscan solution for injection is a dark purple solution in an amber glass vial, containing 1 ml, 3 ml or 6 ml of solution.
Croatian: Foscan otopina za injekciju tamnoljubičasta je otopina u bočici od smeđeg stakla, koja sadrži 1 ml, 3 ml ili 6 ml otopine.
English: • Do not use UV sunbeds or sunbathe for 3 months after Foscan injection.
Croatian: • Nemojte odlaziti u solarij niti se sunčati 3 mjeseca nakon injekcije Foscana.
English: Foscan 1 mg/ml solution for injection
Croatian: Foscan 1 mg/ml otopina za injekciju
English: You can gradually return to normal indoor lighting.
Croatian: Možete se postupno vratiti na uobičajenu umjetnu rasvjetu u zatvorenim prostorima.
English: Administer the required dose of Foscan by slow intravenous injection, over not less than 6 minutes (Figure 4).
Croatian: Primijenite potrebnu dozu Foscana sporom intravenskom injekcijom u trajanju od najmanje 6 minuta (slika 4).
English: Each vial represents a single dose and any unused solution must be discarded.
Croatian: Jedna bočica predstavlja jednu dozu i sva neiskorištena otopina mora se baciti.
English: Foscan 1 mg/ml solution for injection Temoporfin
Croatian: Foscan 1 mg/ml otopina za injekciju temoporfin
English: Each pack provides 1 vial containing 1 ml, 3 ml or 6 ml solution for injection.
Croatian: Jedno pakiranje sadrži 1 bočicu koja sadrži 1 ml, 3 ml ili 6 ml otopine za injekciju.
English: - The active substance is temoporfin.
Croatian: - Djelatna tvar je temoporfin.
English: • Sepsis
Croatian: • Sepsa.
English: If you have any further questions on the use of this medicine, ask your doctor or nurse.
Croatian: U slučaju bilo kakvih pitanja u vezi s primjenom ovog lijeka, obratite se svom liječniku ili medicnskoj sestri.
English: The excipients are ethanol anhydrous and propylene glycol.
Croatian: Pomoćne tvari su etanol, bezvodni i propilenglikol.
English: biolitec Pharma Ltd. Otto-Schott-Str. 15 07745 Jena Germany
Croatian: Otto-Schott-Str. 15 07745 Jena
English: Regarding the tabulated adverse reactions gastrointestinal disorders, adverse skin reactions and general disorders and administration site conditions are the most frequently observed adverse reactions.
Croatian: Među nuspojavama u tablici, poremećaji probavnog sustava, kožne nuspojave i opći poremećaji i reakcije na mjestu primjene najčešće su opažene nuspojave.
English: A filter with Luer lock connections for syringe and cannula is provided.
Croatian: Priložen je filtar s nastavkom tipa Luer lock za spoj sa štrcaljkom i kanilom.
English: • There may be some irritation, a burning sensation or skin damage where Foscan is injected,
Croatian: • Može nastati nadraženost, žarenje ili oštećenje kože na mjestu gdje je ubrizgan Foscan, ali to neće dugo trajati.
English: For intravenous use Read the package leaflet before use.
Croatian: Za primjenu u venu Prije uporabe pročitajte uputu o lijeku.
English: The required dose of Foscan is administered by slow intravenous injection, over not less than 6 minutes.
Croatian: Potrebna doza Foscana primjenjuje se sporom intravenskom injekcijom u trajanju od najmanje 6 minuta.
English: Pain in the photoactivated area, e.g. facial pain, headache, injection site pain, oedema in the photoactivated area, e.g. face oedema, tongue oedema
Croatian: Opći poremećaji i reakcije na mjestu primjene Vrlo često: Bol u fotoaktiviranom području, npr. bol na licu, glavobolja, bol na mjestu injekcije, edem u fotoaktiviranom području, npr. edem lica, edem jezika
English: VIAL LABEL OF 1 MG/ML
Croatian: KUTIJA ZA 1 MG/ML
English: The active substance is temoporfin.
Croatian: Djelatna tvar je temoporfin.
English: Most of the side effects related with photodynamic therapy are local effects seen as consequence of triggering the Foscan with the laser. You may feel pain after the laser treatment.
Croatian: Većina nuspojava povezanih s fotodinamskom terapijom su lokalni učinci koji se smatraju posljedicom poticanja lijeka Foscan laserom.
English: Thermal burn, sunburn
Croatian: Toplinska opekotina, opekotina od sunca
English: For 6 months following Foscan treatment, care should be taken to avoid direct prolonged sunlight exposure of the arm used for Foscan injection.
Croatian: Tijekom 6 mjeseci nakon liječenja Foscanom, potrebno je paziti da se izbjegava produljeno izlaganje ruke u koju je dana injekcija Foscana izravnoj sunčevoj svjetlosti.
English: • Please speak to your doctor about this before you go home after being injected with Foscan.
Croatian: • Kada dobijete injekciju Foscana, molimo da o tome porazgovarate s liječnikom prije nego što odete kući.
English: Once removed from its packaging it must be administered immediately.
Croatian: Nakon što se izvadi iz pakiranja, mora se odmah primijeniti.
English: Type I amber glass vials with a bromobutyl elastomer stopper and aluminium seal containing either 1 ml or 3 ml or 6 ml of solution for injection.
Croatian: I s bromobutilnim elastomernim čepom i aluminijskim prstenom koje sadrže 1 ml ili 3 ml ili 6 ml otopine za injekciju.
English: Foscan is non-irritant.
Croatian: Foscan nije nadražujuće sredstvo.
English: The dark purple colour of the solution together with the amber vial makes a visual check for particulates impossible.
Croatian: Tamnoljubičasta boja otopine i smeđa boja bočice onemogućuju vizualnu provjeru otopine na čestice.
English: Solution for injection Dark purple solution
Croatian: Otopina za injekciju Tamnoljubičasta otopina
English: Like all medicines, Foscan can cause side effects.
Croatian: Moguće nuspojave Kao i svi lijekovi, ovaj lijek može uzrokovati nuspojave.
English: The incident light dose is 20 J/cm 2, delivered at an irradiance of 100 mW/cm to the tumour surface,
Croatian: Doza upadne svjetlosti je 20 J/cm2, a dostavljeni intenzitet zračenja iznosi 100 mW/cm površine tumora, što znači da je vrijeme obasjavanja približno 200 sekundi.
English: For 3 months following Foscan treatment, avoid UV tanning beds.
Croatian: Tijekom 3 mjeseca nakon liječenja Foscanom, izbjegavajte uređaje za umjetno tamnjenje kože UV zrakama (solarije).
English: As a precautionary measure, if prolonged outdoor activity is planned, the injection arm should be protected by wearing long sleeved, coloured clothing.
Croatian: Kao mjeru opreza, ako se planira dugotrajni boravak na otvorenom, ruku u koju je ubrizgana injekcija treba zaštititi nošenjem tamne odjeće dugih rukava.
English: Discard the remainder after use.
Croatian: Preostali lijek nakon primjene bacite.
English: Haemorrhage
Croatian: Fistula
English: • Fever
Croatian: • Vrućica.
English: The active ingredient in Foscan is temoporfin.
Croatian: Što je Foscan i za što se koristi Djelatna tvar u Foscanu je temoporfin.
English: • Vomiting
Croatian: • Povraćanje.
English: • Difficulty with swallowing
Croatian: • Otežano gutanje.
English: B. PACKAGE LEAFLET
Croatian: SADRŽAJ PAKIRANJA
English: Name and address of the manufacturer responsible for batch release biolitec Pharma Ltd. Otto-Schott-Str. 15 07745 Jena Germany
Croatian: Naziv i adresa proizvođača odgovornog za puštanje serije lijeka u promet biolitec Pharma Ltd.
English: Common: Dizziness, burning sensation
Croatian: Omaglica, osjećaj žarenja
English: Foscan must be administered intravenously via an in-dwelling cannula in a large proximal limb vein, preferably in the antecubital fossa.
Croatian: PRIMJENA FOSCANA (96 sati prije obasjavanja mjesta liječenja laserom) Foscan se mora primijeniti intravenski putem trajne kanile postavljene u veliku venu na gornjem ekstremitetu, po mogućnosti u lakatnoj jami.
English: • Nausea
Croatian: • Mučnina.
English: Common: Trismus Unknown: Fistula
Croatian: Često: Trizmus3
English: The patency of the in-dwelling cannula should be tested before injection.
Croatian: Prije injiciranja potrebno je provjeriti prohodnost trajne kanile.
English: • Giddiness
Croatian: • Omaglica.
English: Respiratory, thoracic and mediastinal disorders Unknown: Airway obstruction
Croatian: Ruptura stijenke krvne žile; vidjeti dio 4.3 Poremećaji dišnog sustava, prsišta i sredoprsja Nepoznato: Opstrukcija dišnih puteva
English: • Vascular rupture
Croatian: Tablični sažetak nuspojava
English: • Burns
Croatian: • Opekotine.
English: • You may get constipation.
Croatian: • Možete razviti zatvor.
English: To be taken into account in pregnant or breast-feeding women, children and high-risk groups such as patients with liver disease or epilepsy.The amount of alcohol in this medicinal product may alter the effects of other medicines.The amount of alcohol in this medicinal product may impair the ability to drive or use machines.
Croatian: To je potrebno uzeti u obzir u trudnica, dojilja, djece te visokorizičnih skupina ljudi poput bolesnika s bolešću jetre ili epileptičara.
English: Roche România SRL Piata Presei Libere , Nr. 3-5, Clădirea City Gate -Turnul de Sud, Etajele 4A, 5 şi 6, Sector 1, Bucureşti
Croatian: Roche România SRL Piata Presei Libere , Nr. 3-5, Clădirea City Gate -Turnul de Sud, Etajele 4A, 5 şi 6, Sector 1, Bucureşti, România
English: ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDER IN THE MEMBER STATES
Croatian: POPIS NAZIVA, FARMACEUTSKIH OBLIKA, JAČINA LIJEKOVA, PUTEVA PRIMJENE, NOSITELJA ODOBRENJA
English: Roche Bulgaria EOOD 16, Byalo pole Str. 1618 Sofia, Bulgaria
Croatian: Roche Bulgaria EOOD 16, Byalo pole Str. 1618 Sofia,
English: Bratislava 811 08
Croatian: Cintorínska 3/A Bratislava 811 08
English: Ulica grada Vukovara 269a 10 000 Zagreb Croatia
Croatian: Ulica grada Vukovara 269a
English: Roche Polska Sp. z o.o.
Croatian: Roche Polska Sp. z o.o. ul.
English: Czech Republic Roche s.r.o.
Croatian: Češka Republika Roche s.r.o.
English: United Kingdom Roche Products Limited, 6 Falcon Way, Shire Park, Welwyn Garden City,
Croatian: 6 Falcon Way, Shire Park,
English: Belgium N.V. Roche S.A. Rue Dante 75
Croatian: Roche S.A. Rue Dante 75
English: Cymeven® i. v.
Croatian: Cymeven® i.
English: Roche (Hungary) Ltd. Edison str 1.
Croatian: Roche (Hungary) Ltd.
English: Slovak Republic Roche Slovensko s.r.o.
Croatian: Roche Slovensko s.r.o.
English: AL7 1TW,
Croatian: Welwyn Garden City, AL7 1TW,
English: 500 mg Lyophilisate for parenteral use (infusion)
Croatian: 500 mg Liofilizat za parenteralnu primjenu (infuzija)
English: 3446 GR Woerden
Croatian: Beneluxlaan 2a 3446 GR Woerden The Netherlands
English: ul.
Croatian: G.
English: 4, Alamanas & Delfon str. 151 25 Maroussi Greece
Croatian: 4, Alamanas & Delfon str.
English: The Netherlands Roche Nederland B.V. Beneluxlaan 2a
Croatian: Roche Nederland B.V.
English: G. A. Stamatis & Co. Ltd. 27, Andreas Araouzos P.O.
Croatian: A. Stamatis & Co.
English: Cymevene "Roche" 500 mg - Trockensubstanz zur Infusionsbereitung
Croatian: Cymevene "Roche" 500 mg
English: E-mail: medwiss@1apharma.com
Croatian: E-pošta: medwiss@1apharma.com
English: Contains sodium benzoate (E 211).
Croatian: Sadrži natrijev benzoat (E 211).
English: Clinical studies in Alzheimer's dementia
Croatian: Klinička ispitivanja kod Alzheimerove demencije
English: If you find you have forgotten to take your dose of Rivastigmine 1 A Pharma, wait and take the next dose at the usual time.
Croatian: Ako primijetite da ste zaboravili uzeti svoju dozu Rivastigmina 1 A Pharma, pričekajte i uzmite iduću dozu u uobičajeno vrijeme.
English: If you have not taken Rivastigmine 1 A Pharma for more than three days, do not take the next dose until you have talked to your doctor.
Croatian: Ako više od tri dana niste uzeli Rivastigmin 1 A Pharma, nemojte uzimati sljedeću dozu dok se niste posavjetovali sa svojim liječnikom.
English: 82041 Oberhaching Germany
Croatian: 82041 Oberhaching
English: • Hyperactivity (high level of activity, restlessness) Not known (frequency cannot be estimated from the available data)
Croatian: • Hiperaktivnost (visoka razina aktivnosti, nemir) Nije poznato (ne može se procijeniti iz dostupnih podataka)
English: Patients without visual hallucinations
Croatian: Bolesnici bez vizualnih halucinacija
English: If you accidentally take more Rivastigmine 1 A Pharma than you should, inform your doctor.
Croatian: Ako slučajno uzmete više Rivastigmina 1 A Pharma nego biste trebali, obavijestite svog liječnika.
English: Medicinal product on “restricted” medical prescription, reserved for use in certain specialised area (See Annex I: Summary of Product Characteristics, Section 4.2).
Croatian: Lijek se izdaje na „ograničeni“ recept, rezerviran za primjenu u određenom specijaliziranom području (vidjeti Dodatak I: Sažetak opisa svojstava lijeka, dio 4.2).
English: Rivastigmine 1 A Pharma may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose.
Croatian: Rivastigmin 1 A Pharma može uzrokovati omaglicu i pospanost, pogotovo na početku liječenja ili prilikom povećanja doze.
English: If this applies to you, tell your doctor and do not take Rivastigmine 1 A Pharma.
Croatian: Ako se ovo odnosi na Vas, obratite se svom liječniku i nemojte uzimati Rivastigmin 1 A Pharma.
English: Your doctor will tell you what dose of Rivastigmine 1 A Pharma to take.
Croatian: Liječnik će Vam reći koju dozu Rivastigmina 1 A Pharma trebate uzimati.
English: - if you are allergic to rivastigmine (the active substance of Rivastigmine 1 A Pharma) or any of the other ingredients of this medicine (listed in section 6).
Croatian: - ako ste alergični na rivastigmin (djelatnu tvar Rivastigmina 1 A Pharma) ili neki drugi sastojak ovog lijeka (naveden u dijelu 6).
English: What Rivastigmine 1 A Pharma is and what it is used for
Croatian: Što je Rivastigmin 1 A Pharma i za što se koristi
English: Uncommon (may affect up to 1 in 100 people) • Uneven heartbeat and poor control of movements
Croatian: Manje često (pojavljuje se u 1 na 100 osoba) • Nepravilni otkucaji srca i slaba kontrola pokreta
English: Caution when Rivastigmine 1 A Pharma is taken together with beta-blockers (medicines such as atenolol used to treat hypertension, angina and other heart conditions).
Croatian: Potreban je oprez kod uzimanja Rivastigmina 1 A Pharma zajedno s beta blokatorima (lijekovima kao što je atenolol koji se koristi za liječenje hipertenzije, angine i drugih srčanih stanja).
English: By blocking these enzymes, Rivastigmine 1 A Pharma allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer's disease and dementia associated with Parkinson's disease.
Croatian: Blokirajući te enzime, Rivastigmin 1 A Pharma omogućava povećanje razina acetilkolina u mozgu, što pomaže u smanjivanju simptoma Alzheimerove bolesti i demencije povezane s Parkinsovom bolešću.
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.europa.eu
Croatian: Detaljne informacije o ovom lijeku dostupne su na web stranici Europske agencije za lijekove: http://www.ema.europa.eu
English: Rivastigmine 1 A Pharma should not be given at the same time as metoclopramide (a medicine used to relieve or prevent nausea and vomiting).
Croatian: Rivastigmin 1 A Pharma se ne smije davati istodobno s metoklopramidom (lijekom koji se koristi za ublažavanje ili sprečavanje mučnine i povraćanja).
English: Based on evidence from animal studies the major cytochrome P450 isoenzymes are minimally involved in rivastigmine metabolism.
Croatian: Na temelju dokaza iz ispitivanja na životinjama, u metabolizam rivastigmina minimalno su uključeni glavni izoenzimi citokroma P450.
English: Content of the pack and other information What Rivastigmine 1 A Pharma contains
Croatian: Sadržaj pakiranja i druge informacije Što Rivastigmin 1 A Pharma sadrži
English: - The other ingredients are hypromellose, magnesium stearate, microcrystalline cellulose, colloidal anhydrous silica, gelatin, yellow iron oxide , red iron oxide , titanium dioxide and shellac.
Croatian: - Ostali sastojci su: hipromeloza, magnezijev stearat, mikrokristalična celuloza, koloidni bezvodni silicijev dioksid, želatina, žuti željezov oksid, crveni željezov oksid, titanijev dioksid i šelak.
English: Rivastigmine 1 A Pharma is used for the treatment of adult patients with mild to moderately severe Alzheimer's dementia, a progressive brain disorder that gradually affects memory, intellectual ability and behaviour.
Croatian: Rivastigmin 1A Pharma se primjenjuje za liječenje odraslih bolesnika s blago do umjereno teškom Alzheimerovom demencijom, progresivnim poremećajem mozga koji postupno utječe na pamćenje, intelektualnu sposobnost i ponašanje.